Yuyu Pharma Statistics

Total Valuation

Yuyu Pharma has a market cap or net worth of KRW 71.85 billion. The enterprise value is 75.81 billion.

Market Cap	71.85B
Enterprise Value	75.81B

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Yuyu Pharma has 16.18 million shares outstanding. The number of shares has increased by 25.44% in one year.

Current Share Class	n/a
Shares Outstanding	16.18M
Shares Change (YoY)	+25.44%
Shares Change (QoQ)	-48.99%
Owned by Insiders (%)	34.99%
Owned by Institutions (%)	0.27%
Float	10.52M

Valuation Ratios

The trailing PE ratio is 8.40.

PE Ratio	8.40
Forward PE	n/a
PS Ratio	0.53
PB Ratio	0.60
P/TBV Ratio	0.62
P/FCF Ratio	2.99
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.27, with an EV/FCF ratio of 3.16.

EV / Earnings	8.86
EV / Sales	0.56
EV / EBITDA	4.27
EV / EBIT	6.26
EV / FCF	3.16

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.27.

Current Ratio	1.70
Quick Ratio	1.02
Debt / Equity	0.27
Debt / EBITDA	1.95
Debt / FCF	1.48
Interest Coverage	4.81

Financial Efficiency

Return on equity (ROE) is 8.21% and return on invested capital (ROIC) is 4.76%.

Return on Equity (ROE)	8.21%
Return on Assets (ROA)	3.96%
Return on Capital (ROIC)	4.76%
Revenue Per Employee	532.77M
Profits Per Employee	33.82M
Employee Count	253
Asset Turnover	0.68
Inventory Turnover	1.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.00% in the last 52 weeks. The beta is 0.51, so Yuyu Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-21.00%
50-Day Moving Average	4,336.80
200-Day Moving Average	4,712.35
Relative Strength Index (RSI)	55.64
Average Volume (20 Days)	361,882

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Yuyu Pharma had revenue of KRW 134.79 billion and earned 8.56 billion in profits. Earnings per share was 528.75.

Revenue	134.79B
Gross Profit	51.10B
Operating Income	12.60B
Pretax Income	10.80B
Net Income	8.56B
EBITDA	18.24B
EBIT	12.60B
Earnings Per Share (EPS)	528.75

Full Income Statement

Balance Sheet

The company has 43.88 billion in cash and 35.64 billion in debt, giving a net cash position of 8.24 billion or 509.32 per share.

Cash & Cash Equivalents	43.88B
Total Debt	35.64B
Net Cash	8.24B
Net Cash Per Share	509.32
Equity (Book Value)	131.25B
Book Value Per Share	7,356.73
Working Capital	43.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 28.75 billion and capital expenditures -4.75 billion, giving a free cash flow of 24.01 billion.

Operating Cash Flow	28.75B
Capital Expenditures	-4.75B
Free Cash Flow	24.01B
FCF Per Share	1,483.42

Full Cash Flow Statement

Margins

Gross margin is 37.91%, with operating and profit margins of 9.35% and 6.21%.

Gross Margin	37.91%
Operating Margin	9.35%
Pretax Margin	8.01%
Profit Margin	6.21%
EBITDA Margin	13.53%
EBIT Margin	9.35%
FCF Margin	17.81%

Dividends & Yields

Yuyu Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.44%
Shareholder Yield	-25.44%
Earnings Yield	11.91%
FCF Yield	33.41%

Dividend Details

Stock Splits

The last stock split was on March 30, 2021. It was a forward split with a ratio of 2.

Last Split Date	Mar 30, 2021
Split Type	Forward
Split Ratio	2

Scores

Yuyu Pharma has an Altman Z-Score of 2.04. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	n/a